TABLE 2.

Results of laboratory investigations performed within 3 months of the liver biopsy

Variable	No psychotropic medications (n=208)	Receiving psychotropic medications (n=17)	P
ALT (U/L)	85 (26–429)	79 (35–199)	0.68
AST (U/L)	49 (15–240)	41 (21–132)	0.18
GGT (U/L)	47 (12–710)	52 (17–115)	0.84
Alkaline Phosphatase (U/L)	171 (55–465)	196 (78–408)	0.59
HbA1c (%)	5.2 (4.3–8.8)	5.1 (4.4–10.1)	0.90
HOMA-IR	6.0 (0.8–69)	6.3 (1.4–14.8)	0.92
LDL (mg/dL)	91 (33–182)	109 (20–202)	0.09
HDL (mg/dL)	38 (19–64)	35 (15–51)	0.11
Triglycerides (mg/dL)	142 (49–495)	149 (88–721)	0.12
Steatosis	2 (0–3)	3 (1–3)	0.039
Lobular inflammation	1 (0–3)	1 (0–2)	0.53
Ballooning degeneration	1 (0–2)	1 (0–2)	0.94
NAFLD activity score	4 (1–8)	5 (2–6)	0.17
Portal inflammation	1 (0–2)	1 (0–1)	0.53
Fibrosis severity	1 (0–3)	1 (0–3)	0.70

Data are presented as medians (ranges).